Who We Serve

Our clients are:

• Life sciences companies: biotechnology, pharmaceutical,
   bioinformatics, diagnostics, medical devices, etc.

• Emerging growth companies: start-ups, pre-IPO, newly public,
   emerging and established companies.

• Companies seeking to build visibility and acceptance among
   key audiences, especially the media, corporate partners or acquirers
   and the financial community.



Our current and long-term client roster includes:

  • AVANT Immunotherapeutics (Nasdaq: AVAN) www.AvantImmune.com

  • Biogen Idec (Nasdaq: BIIB) www.BiogenIdec.com

  • ChemGenex Pharmaceuticals www.Chemgenex.com

  • The Gibson Network

  • InSite Vision www.InsiteVision.com

  • Intranasal Therapeutics www.Intranasal.com

  • KaloBios Pharmaceuticals www.KaloBios.com

  • Luca Technologies www.LucaTechnologies.com

  • Lux Biosciences www.LuxBio.com

  • Neurologix www.Neurologix.com

  • New Zealand Trade and Enterprise - Biotechnology www.www.nzte.govt.nz

  • NextBio www.NextBio.com

  • Nucleonics www.NucleonicsInc.com

  • Origen Therapeutics www.OrigenTherapeutics.com

  • Sapphire Therapeutics www.SapphireThera.com

  • Somnus Therapeutics

  • Trellis Bioscience www.TrellisBio.com

  • XOMA (US), LLC (Nasdaq: XOMA) www.xoma.com